Personalized Neoantigen Vaccine in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy
Conditions
- Resectable Pancreatic Cancer
Interventions
- BIOLOGICAL: iNeo-Vac-P01
- OTHER: GM-CSF
Sponsor
Zhejiang Provincial People's Hospital
Collaborators